[1]
B. Jones, R. Syme, M. Eliasziw, and B. J. Eigl, “Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?”, CUAJ, vol. 7, no. 3-4, pp. e231–6, Apr. 2013.